SoFi Technologies Inc vs State Street SPDR S&P Biotech ETF — how do they compare? SoFi Technologies Inc trades at $17.63 (market cap $21.82B), while State Street SPDR S&P Biotech ETF trades at $154.46. The key difference: State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, SoFi Technologies Inc nearer its low. Which is the better fit depends on your goals.
| SOFI | XBI | |
|---|---|---|
Market Cap | $21.82B | — |
Sector | Financials | Broad Market / Factor |
52-Week High | $32.21 | $164.28 |
52-Week Low | $15.15 | $85.16 |
Trailing returns across standard periods
Latest headlines on both assets
SoFi is a financial services company that was founded in 2011 and is currently based in San Francisco. Initially known for its student loan refinancing business, the company has expanded its product offerings to include personal loans, credit cards, mortgages, investment accounts, banking services, and financial planning. The company intends to be a one-stop shop for its clients' finances and operates solely through its mobile app and website. Through its acquisition of Galileo in 2020 the company also offers payment and account services for debit cards and digital banking.
Read more on SOFI →XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →